1. Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis

   • Mari Kihara
   • Rebecca Davies
   • on behalf of the British Society for Rheumatology Biologics Register

   Original Article Open access 02 December 2016 Pages: 241 - 250

   

2. Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study

   • Paola Cipriani
   • Onorina Berardicurti
   • Roberto Giacomelli

   Original Article 25 October 2016 Pages: 251 - 260

3. The additional benefit of ultrasonography to 2010 ACR/EULAR classification criteria when diagnosing rheumatoid arthritis in the absence of anti-cyclic citrullinated peptide antibodies

   • Lanlan Ji
   • Xuerong Deng
   • Zhuoli Zhang

   Original Article 15 November 2016 Pages: 261 - 267

   

4. Hormone, metabolic peptide, and nutrient levels in the earliest phases of rheumatoid arthritis—contribution of free fatty acids to an increased cardiovascular risk during very early disease

   • Man Wai Tang
   • Frieda A. Koopman
   • Paul Peter Tak

   Original Article Open access 02 November 2016 Pages: 269 - 278

   

5. Methotrexate intolerance in the treatment of rheumatoid arthritis (RA): effect of adding caffeine to the management regimen

   • Anand Narayan Malaviya

   Original Article 06 September 2016 Pages: 279 - 285

   

6. Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis

   • Han Cen
   • Hua Huang
   • Ren-Jie Zhuo

   Original Article 16 July 2016 Pages: 287 - 297

   

7. Interleukin 12B gene polymorphisms and susceptibility to rheumatoid arthritis: a data synthesis

   • Xiaoqin Yang
   • Fei Xiao
   • Shuang Liang

   Original Article 16 June 2016 Pages: 299 - 307

   

8. Serum level of reactive oxygen metabolites (ROM) at 12 weeks of treatment with biologic agents for rheumatoid arthritis is a novel predictor for 52-week remission

   • Arata Nakajima
   • Yasuchika Aoki
   • Koichi Nakagawa

   Original Article 17 November 2016 Pages: 309 - 315

   

9. Rheumatologists’ adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission

   • G. Akdemir
   • I.M. Markusse
   • C.F. Allaart

   Original Article Open access 28 September 2016 Pages: 317 - 326

   

10. Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus

    • Tünde Tarr
    • Gábor Papp
    • Margit Zeher

    Original Article 26 November 2016 Pages: 327 - 333

    

11. Plasma ficolin levels and risk of nephritis in Danish patients with systemic lupus erythematosus

    • Nima Tanha
    • Katrine Pilely
    • Søren Jacobsen

    Original Article 15 December 2016 Pages: 335 - 341

    

12. Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality

    • Alimohammad Fatemi
    • Mohammad Matinfar
    • Abbas Smiley

    Original Article 23 December 2016 Pages: 343 - 350

    

13. Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients

    • Julia G. Harris
    • Kristyn I. Maletta
    • Judyann C. Olson

    Original Article 24 December 2016 Pages: 351 - 359

    

14. Juvenile dermatomyositis: a tertiary center experience

    • Kenan Barut
    • Pinar Ozge Avar Aydin
    • Ozgur Kasapcopur

    Original Article 05 January 2017 Pages: 361 - 366

15. Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis

    • Ufuk İlgen
    • Müçteba Enes Yayla
    • Nurşen Düzgün

    Original Article 22 November 2016 Pages: 367 - 372

    

16. The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients

    • Brooke Levis
    • Linda Kwakkenbos
    • and the Canadian Scleroderma Research Group

    Original Article 10 December 2016 Pages: 373 - 379

17. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity

    • M. Michelfelder
    • M. Becker
    • G. Riemekasten

    Original Article 27 December 2016 Pages: 381 - 390

    

18. Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F⁺IL-23⁺ CD161⁺ CD4⁺ T helper cells in psoriatic arthritis joints

    • Ugo Fiocco
    • Roberto Stramare
    • Enrico Grisan

    Original Article 20 December 2016 Pages: 391 - 399

    

19. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients

    • Lei Zhu
    • Chun Li
    • Z. G. Li

    Original Article 03 January 2017 Pages: 401 - 406

20. Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome

    • Shulan Zhang
    • Ziyan Wu
    • Yongzhe Li

    Original Article 21 December 2016 Pages: 407 - 412

    

21. National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA

    • Yusuke Okubo
    • Kotaro Nochioka
    • Robert P. Sundel

    Original Article 16 December 2016 Pages: 413 - 419

    

22. Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants

    • Hafize Emine Sönmez
    • Ezgi Deniz Batu
    • Seza Özen

    Original Article 27 September 2016 Pages: 421 - 425

    

23. Impact of the size and number of swollen joints on serum C-reactive protein level and erythrocyte sedimentation rate in rheumatoid arthritis: a cross-sectional study in Japan

    • Kota Shimada
    • Akiko Komiya
    • Shigeto Tohma

    Brief Report 23 November 2016 Pages: 427 - 431

    

24. Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels

    • Hiroyuki Wakiguchi
    • Syuji Takei
    • Yoshifumi Kawano

    Brief Report 30 November 2016 Pages: 433 - 437

    

25. Treatment with ustekinumab in a Spanish cohort of patients with psoriasis and psoriatic arthritis in daily clinical practice

    • Miriam Almirall
    • Jesús Rodriguez
    • Fernando Gallardo

    Brief Report 05 November 2016 Pages: 439 - 443

26. Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics

    • Jurgen Sota
    • Antonio Vitale
    • Luca Cantarini

    Brief Report 31 July 2016 Pages: 445 - 449

    

27. Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study

    • Antonio Vitale
    • Giacomo Emmi
    • Luca Cantarini

    Brief Report 27 September 2016 Pages: 451 - 455

28. The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis

    • Giovanna Cuomo
    • Virginia D’Abrsca
    • Ilenia Pantano

    Brief Report 05 November 2016 Pages: 457 - 461

29. A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome

    • Donato Rigante
    • Antonio Vitale
    • Luca Cantarini

    Brief Report 01 June 2016 Pages: 463 - 468

30. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis

    • Angela Ceribelli
    • Natasa Isailovic
    • Carlo Selmi

    Brief Report 20 October 2016 Pages: 469 - 475

    

31. Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis

    • Nehal Narayan
    • Shirley Rigby
    • Francesco Carlucci

    Case Based Review Open access 24 October 2016 Pages: 477 - 479

32. Neuromyotonia as an unusual neurological complication of primary Sjögren’s syndrome: case report and literature review

    • Fei Xiao

    Case Based Review 12 December 2016 Pages: 481 - 484